VivoSim Labs, Inc. Debt Securities, Available-for-sale
VivoSim Labs, Inc. (VIVS) had Debt Securities, Available-for-sale of $497.00 thousand as of 2024-12-31, per its 10-Q filed 2025-02-19.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-06-05
- 2024-12-31: Debt Securities, Available-for-sale $497.00K.
- 2024-09-30: Debt Securities, Available-for-sale $995.00K.
- 2024-06-30: Debt Securities, Available-for-sale $1.49M.
- 2024-03-31: Debt Securities, Available-for-sale $998.00K.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-12-31 | $497.00K 10-Q · filed 2025-02-19 |
| 2024-09-30 | $995.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.49M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $998.00K 10-K · filed 2025-06-05 |
| 2023-12-31 | $2.00M 10-Q · filed 2024-02-08 |
| 2023-09-30 | $2.99M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.99M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $4.95M 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |